Atrial fibrillation (AF), the most common cardiac arrhythmia worldwide, is driven by complex
mechanisms that differ between subgroups of patients. This complexity is apparent from the …

Antiarrhythmic drugs (AADs) have a therapeutic effect on atrial fibrillation (AF) by regulating
the function of ion channels. However, several adverse effects and high recurrence rates …

Atrial tachyarrhythmias and worsening heart failure frequently coexist and potentially
progress to a life threatening condition. Therapeutic approach requires simultaneous …

A hallmark of atrial fibrillation is an excess of spontaneous calcium release events, which
can be mimicked by β1-or β2-adrenergic stimulation. Because β1-adrenergic receptor …

Atrial fibrillation (AF) and heart failure (HF) are common chronic diseases noted in humans.
AF and HF share several risk factors, such as age, hypertension, obesity, diabetes, and …

The purpose of this review is to describe the impact of atrial fibrillation (AF) on the
cardiovascular outcomes and prognosis in patients with Takotsubo Cardiomyopathy (TTC) …

A hallmark of atrial fibrillation is an excess of spontaneous calcium release events, which
can be mimicked by ß1-or ß2-adrenergic stimulation. Because ß1-adrenergic receptor …

A hallmark of atrial fibrillation is an excess of spontaneous calcium release events, which
can be mimicked by β1-or β2-adrenergic stimulation. Because β1-adrenergic receptor …

Atrial fibrillation (AF), the most common cardiac arrhythmia, emerges as one of the world's
major health issues associated with significant morbidity and mortality. Metabolic syndrome …

Intracellular Ca 2+ is an important regulator in cardiac electrophysiology and contraction
under both physiology and pathophysiology. The regular excitation and effective contraction …